drugset / Trial / NCT04308811
Autologous Platelet-Rich Plasma in the Management of Asherman Syndrome
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of the study is to find out the benefit of the platelet-rich plasma in preventing reformation of intrauterine adhesions after adhesiolysis in cases of Asherman syndrome
Timeline
- Start
- 2019-08-10
- Primary completion
- 2020-02-20
- Completion
- 2020-02-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Platelet Rich Plasma | Other / unclassified | — | Other |
| Subject | amniotic membrane graft | Unknown | — | Other |